Year1
,
- Bristol-Myers Squibb Pharmaceutical Company of the United States and Novartis Pharmaceuticals of Switzerland have recently developed two new drugs for the treatment of chronic myeloid leukemia, which are expected to make up for the drug resistance shortcomings of Gleevec (), the current specific drug for the treatment of the disease. Although They are still in the second phase of clinical drug research, and generally new drugs can only enter the field of large-scale application after completing the third phase of clinical trials. However, these two new drugs have attracted the attention of the industry and patients because of their remarkable efficacy.
What is the real price of Gleevec in India 15010438677
价格
Negotiable
- total supply
- 11 瓶
- MOQ
- 1 瓶
- area
- Beijing
- Delivery period：
- Shipped within 3 days from the date of payment by the buyer
Buyers are still looking
- The project applicat￥1.00/瓶
- Chengdu Zhisai profeNegotiable
- Knowledge contest anNegotiable
- Company registration￥300.00/瓶
- Application of recycNegotiable
- Classic case of soci￥1.00/瓶
- Feasibility study re￥1.00/瓶
- Social security outsNegotiable
- What is social securNegotiable
WhatsApp
